neostigmine has been researched along with Dyskinesia, Medication-Induced in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Excerpt | Relevance | Reference |
---|---|---|
"Deanol was not found to be effective in this group of patients; the authors suggest that this drug should not be assumed to be generally effective unless effectiveness is verified by a large placebo-controlled double-blind study." | 2.64 | Cholinergic influences in tardive dyskinesia. ( Chang, S; Davis, JM; Ericksen, SE; Smith, RC; Tamminga, CA, 1977) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tamminga, CA | 1 |
Smith, RC | 1 |
Ericksen, SE | 1 |
Chang, S | 1 |
Davis, JM | 1 |
1 trial available for neostigmine and Dyskinesia, Medication-Induced
Article | Year |
---|---|
Cholinergic influences in tardive dyskinesia.
Topics: Acetylcholine; Administration, Oral; Basal Ganglia; Choline; Deanol; Dyskinesia, Drug-Induced; Ethan | 1977 |